Gao and colleagues describe the characterization of an erythrocyte–anti-PD1 conjugate, reporting antitumor activity in preclinical models and results of a first-in-human clinical trial in persons with advanced solid tumors resistant to anti-PD(L)1.
- Xiaoqian Nie
- Yuehua Liu
- Xiaofei Gao
